ODYSSEY THERAPEUTICS Stock Price, News & Analysis
Company Description
ODYSSEY THERAPEUTICS (NASDAQ: ODTX) is a publicly traded biotechnology company in the Biological Products, (no Diagnostic Substances) sector. The company has a market capitalization of $855.0M, ranking #3,087 among all listed U.S. companies by market cap.
ODTX stock has gained 10.0% over the past year, placing it at #1,889 in year-to-date performance among tracked companies. Shares last traded at $18.06.
This page provides a comprehensive overview of ODTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ODYSSEY THERAPEUTICS (ODTX) stock last traded at $18.06. Over the past 12 months, the stock has gained 10.0%. At a market capitalization of $855.0M, ODTX is classified as a small-cap stock with approximately 48.0M shares outstanding.
ODTX Rankings
Latest News
ODYSSEY THERAPEUTICS has 2 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include earnings, IPO, offering. View all ODTX news →
SEC Filings
ODYSSEY THERAPEUTICS has filed 5 recent SEC filings, including 2 Form 8-K, 2 Form SCHEDULE 13G, 1 Form 10-Q. The most recent filing was submitted on June 23, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ODTX SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in ODYSSEY THERAPEUTICS (ODTX) currently stands at 514.4 thousand shares, up 494.7% from the previous reporting period, representing 1.2% of the float. Over the past 12 months, short interest has increased by 494.7%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for ODYSSEY THERAPEUTICS (ODTX) currently stands at 1.5 days, up 54% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 54% over the past year, indicating either rising short interest or declining trading volume.
ODTX Company Profile & Sector Positioning
ODYSSEY THERAPEUTICS (ODTX) operates in the Biotechnology industry within the broader Biological Products, (no Diagnostic Substances) sector and is listed on the NASDAQ. In monthly performance, the stock ranks #1,485 among all tracked companies.